Different oxygen treatment pressures alter inflammatory gene expression in human endothelial cells

Undersea and Hyperbaric Medicine

Volumn 40, Issue 2, 2013, Pages 115-123

  Kendall, Alexandra C ^a,b   Whatmore, Jacqueline L ^a   Harries, Lorna W ^a   Winyard, Paul G ^a   Eggleton, Paul ^a,c   Smerdon, Gary R ^b  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b Diving Diseases Research Centre   (United Kingdom)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CD31 ANTIGEN; ED B FIBRONECTIN PROTEIN, HUMAN; ED-B FIBRONECTIN PROTEIN, HUMAN; FIBRONECTIN; MESSENGER RNA;

ANGIOGENESIS; APOPTOSIS; ARTICLE; ATMOSPHERIC PRESSURE; CELL HYPOXIA; CHRONIC DISEASE; DIABETIC FOOT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HYPERBARIC OXYGEN; INJURY; METABOLISM; METHODOLOGY; OXIDATION REDUCTION REACTION; PHYSIOLOGY; STANDARD; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIGENS, CD31; APOPTOSIS; ATMOSPHERIC PRESSURE; CELL HYPOXIA; CHRONIC DISEASE; DIABETIC FOOT; FIBRONECTINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERBARIC OXYGENATION; INFLAMMATION MEDIATORS; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATION-REDUCTION; RNA, MESSENGER; WOUNDS AND INJURIES;

EID: 84876910803     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Abidia A, Laden G, Kuhan G et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. European Journal of Vascular and Endovascular Surgery, 2003; 25(6):513-518.
2. Londahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care, 2010; 33(5):998-1003.
3. Sheffield PJ. How the Davis 2.36 ATA wound healing enhancement treatment table was established. Undersea and Hyperbaric Medicine, 2004; 31(2):193-194.
4. Trengove NJ, Bielefeldt-Ohmann H, Stacey MC. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair and Regeneration, 2000; 8(1):13-25.
5. Diegelmann RF. Excessive neutrophils characterize chronic pressure ulcers. Wound Repair and Regeneration, 2003; 11(6):490-5.
6. Yager DR, Nwomeh BC. The proteolytic environment of chronic wounds. Wound Repair and Regeneration, 1999; 7(6):433-41.
7. Chen Y, Nadi N, Chavko M, Auker C, McCarron R. Microarray analysis of gene expression in rat cortical neurons exposed to hyperbaric air and oxygen. Neurochemical Research, 2009; 34(6):1047-1056.
8. Godman CA, Joshi R, Giardina C, Perdrizet G, Hightower LE. Hyperbaric oxygen treatment induces antioxidant gene expression. Annals of the New York Academy of Sciences, 2010; 1197(1):178-183.
9. Kendall AC, Whatmore JL, Harries LW, Winyard PG, Smerdon, GR, Eggleton, P. Changes in inflammatory gene expression induced by hyperbaric oxygen treatment in human endothelial cells under chronic wound conditions. Experimental Cell Research, 2012; 318(3):207-216.
10. Hopf HW, Gibson JJ, Angeles AP et al. Hyperoxia and angiogenesis. Wound Repair and Regeneration, 2005; 13(6):558-564.
11. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. Journal of Clinical Investigation, 1973; 52(11):2745-56.
12. Eggleton P, Harries L, Alberigo G et al. Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes. Journal of Clinical Immunology, 2010; 30(5):649-658.
13. Tarr JM, Winyard PG, Ryan B et al. Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells. Arthritis and Rheumatism, 2010; 62(10):2919-29.
14. Shaw FL, Winyard PG, Smerdon GR, Bryson PJ, Moody AJ, Eggleton P. Hyperbaric oxygen treatment induces platelet aggregation and protein release, without altering expression of activation molecules. Clinical biochemistry, 2009; 42(6):467-76.
15. Jurell G, Kaijse, L. The influence of varying pressure and duration of treatment with hyperbaric oxygen on the survival of skin flaps. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 1973; 7(1):25-28.
16. Stoller KP. Hyperbaric oxygen therapy (1.5 ATA) in treating sports related TBI/CTE: two case reports. Medical gas research, 2011; 1(1):17.
17. Duff JH, Shibata HR, Vanschaik L, Usher R, Wigmore RA, MacLean LD. Hyperbaric oxygen: a review of treatment in eighty-three patients. Canadian Medical Association journal, 1967; 97(10):510-5.
18. Bass BH. The treatment of varicose leg ulcers by hyperbaric oxygen. Postgraduate medical journal, 1970; 46(537):407-8.
19. Wattel F, Mathieu D, Coget JM, Billard V. Hyperbaric oxygen therapy in chronic vascular wound management. Angiology, 1990; 41(1):59-65.
20. Doctor N, Pandya S, Supe A. Hyperbaric oxygen therapy in diabetic foot. Journal of postgraduate medicine, 1992; 38(3):112-4, 111.
21. Hammarlund C, Sundberg T. Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. Plastic and reconstructive surgery, 1994; 93(4):829-33; discussion 834.
22. Zamboni WA, Wong HP, Stephenson LL, Pfeifer MA. Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. Undersea & hyperbaric medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc, 1997; 24(3):175-9.
23. Kessler L, Bilbault P, Ortega F et al. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes care, 2003; 26(8):2378-82.
24. Markus, YM, Bell, MJ, Evans, AW. Ischemic scleroderma wounds successfully treated with hyperbaric oxygen therapy. The Journal of rheumatology, 2006; 33(8):1694-6.
25. Boykin JV Jr., Baylis C. Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: a preliminary study. Advances in skin & wound care, 2007; 20(7):382-8.
26. Londahl M, Landin-Olsson M, Katzman P. Hyperbaric oxygen therapy improves health-related quality of life in patients with diabetes and chronic foot ulcer. Diabetic medicine : a journal of the British Diabetic Association, 2011; 28(2):186-90.
27. Kaur S, Pawar M, Banerjee N, Garg R. Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. Journal of anaesthesiology, clinical pharmacology, 2012; 28(1):70-5.